WGWhitney D. Gannon

Whitney D. Gannon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Whitney D. Gannon has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • John W. Stokes

    Department of Thoracic Surgery Vanderbilt University Medical Center Nashville TN

    8 shared publications
  • Matthew Bacchetta

    Department of Cardiac Surgery Vanderbilt University Medical Center Nashville TN

    6 shared publications
  • Todd W. Rice

    Division of Allergy, Pulmonary, and Critical Care Medicine Vanderbilt University Medical Center Nashville TN

    6 shared publications
  • Jonathan D. Casey

    Division of Allergy, Pulmonary, and Critical Care Medicine Vanderbilt University Medical Center Nashville TN

    5 shared publications
  • Clayne Benson

    Vanderbilt University Medical Center, Nashville, Tennessee

    4 shared publications
  • Matthew W. Semler

    Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN

    4 shared publications

Latest Publications

  • Open Access

    Protocol and Statistical Analysis Plan for the ECMO-Free Trial: A Multicenter Randomized Controlled Trial

    by Whitney D. Gannon, Ricardo Teijeiro-Paradis, Matthew E. Prekker, Melissa A. Vogelsong, Gary S. Schwartz, Mazen F. Odish, Nils P. Nickel, Sarah L. Bloom, Sydney J. Hansen, Vikram Fielding-Singh, et al.

    Take-Home Points: Study Question: Does a daily protocolized assessment of readiness for decannulation from venovenous extracorporeal membrane oxygenation (V-V ECMO) shorten the time to decannulation? Results: This manuscript describes the protocol and statistical analysis plan for the ECMO-Free Trial, a multicenter randomized trial comparing a protocolized assessment of readiness to decannulate from ECMO versus usual care. Interpretation: Specifying the protocol and full statistical analysis plan before completion of enrollment increases rigor, reproducibility, and transparency of trial results. Background: Decannulation from venovenous extracorporeal membrane oxygenation (V-V ECMO) at the earliest, safe opportunity would be expected to improve patient outcomes. Currently, the manner in which clinicians liberate patients from V-V ECMO is highly variable. Whether performing a daily protocolized assessment of readiness for decannulation decreases the time to decannulation for patients on V-V ECMO is unknown. Research Question: Does the performance of a daily protocolized assessment of readiness to decannulate from ECMO (an “ECMO-free protocol”) decrease the time to successful decannulation compared to usual care among patients receiving V-V ECMO? Study Design and Methods: The ECMO-Free Trial is a pragmatic, multicenter, unblinded, parallel-group, randomized trial being conducted in 7 sites in North America. The trial compares the daily performance of an ECMO-free protocol in which patients who meet safety criteria have their sweep gas flow rate turned to 0 liters per minute (simulating the patient being “off ECMO”) to usual care among 225 adults receiving V-V ECMO. The primary outcome is the time to successful decannulation from ECMO within 60 days. The secondary outcome is the number of ECMO-free days to day 60. Enrollment began on September 7, 2022, and is expected to conclude in 2026. Interpretation: The ECMO-Free Trial will provide important data on the effects of a protocolized assessment of readiness to decannulate vs usual care on the time to decannulation and other outcomes among patients receiving V-V ECMO. Specifying the protocol and statistical analysis plan before the conclusion of enrollment increases the rigor, reproducibility, and transparency of the trial. Trial Registry: ClinicalTrials.gov ; No. NCT05486559 ; URL: www.clinicaltrials.gov

  • Open Access

    Extracorporeal membrane oxygenation as a bridge to lung transplant in the composite lung allocation score era: A single-center experience

    by Whitney D. Gannon, Enock Adjei, John W. Stokes, Todd W. Rice, Anil J. Trindade, Blaine M. Sklar, Christina A. Jelly, Aaron M. Williams, Konrad Hoetzenecker, Caitlin T. Demarest, et al.

  • Open Access

    Reply to Mang et al.

    by Whitney D. Gannon, John W. Stokes, Sean A. Francois, Yatrik J. Patel, Meredith E. Pugh, Clayne Benson, Todd W. Rice, Matthew Bacchetta, Matthew W. Semler, Jonathan D. Casey

  • Open Access

    Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19

    by Whitney D. Gannon, John W. Stokes, Wu Gong, Christopher J. Lindsell, Joseph E. Tonna, Matthew Bacchetta, Todd W. Rice, Matthew W. Semler, Jonathan D. Casey


  • Open Access

    Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment

    by Whitney D. Gannon, John W. Stokes, Sean A. Francois, Yatrik J. Patel, Meredith E. Pugh, Clayne Benson, Todd W. Rice, Matthew Bacchetta, Matthew W. Semler, Jonathan D. Casey


  • Extracorporeal Membrane Oxygenation Selection by Multidisciplinary Consensus: The ECMO Council

    by Whitney D. Gannon, Anil J. Trindade, John W. Stokes, Jonathan D. Casey, Clayne Benson, Yatrik J. Patel, Meredith E. Pugh, Matthew W. Semler, Matthew Bacchetta, Todd W. Rice

    Coronavirus disease 2019 (COVID-19) has increased the demand for extracorporeal membrane oxygenation (ECMO) and introduced distinct challenges to patient selection for ECMO. Standardized processes for patient selection amidst resource limitations are lacking, and data on ECMO consults are underreported. We retrospectively reviewed consecutive adult ECMO consults for acute respiratory failure received at a single academic medical center from April 1, 2020, to February 28, 2021, and evaluated the implementation of a multidisciplinary selection committee (ECMO Council) and standardized framework for patient selection for ECMO. During the 334-day period, there were 202 total ECMO consults; 174 (86.1%) included a diagnosis of COVID-19. Among all consults, 157 (77.7%) were declined and 41 (20.3%) resulted in the initiation of ECMO. Frequent reasons for decline included the presence of multiple relative contraindications (n = 33), age greater than 60 years (n = 32), and resource limitations (n = 27). The ECMO Council deliberated on every case in which an absolute contraindication was not present (n = 96) via an electronic teleconference platform. Utilizing multidisciplinary consensus together with a standardized process for patient selection in ECMO is feasible during a pandemic and may be reliably exercised over time. Whether such an approach is feasible at other centers remains unknown.


  • Safety and Feasibility of a Protocolized Daily Assessment of Readiness for Liberation From Venovenous Extracorporeal Membrane Oxygenation

    by Whitney D. Gannon, John W. Stokes, Sarah Bloom, Wren Sherrill, Matthew Bacchetta, Todd W. Rice, Matthew W. Semler, Jonathan D. Casey


  • Simulation Versus Interactive Mobile Learning for Teaching Extracorporeal Membrane Oxygenation to Clinicians: A Randomized Trial

    by Whitney D. Msn Gannon, John W. Stokes, Meredith E. Md Pugh, Matthew Md Bacchetta, Clayne Benson, Jonathan D. Md Casey, Lynne Bsn Craig, Matthew W. Md Semler, Ashish S. Shah, Ashley Bsn Troutt, et al.

    OBJECTIVES: Extracorporeal membrane oxygenation has become integral to critical care. Data informing optimal extracorporeal membrane oxygenation education modalities are lacking. We aimed to compare the effect of high-fidelity simulation versus interactive mobile learning on extracorporeal membrane oxygenation knowledge acquisition and retention among clinicians. DESIGN: Observer-blinded, randomized controlled trial. SETTING: A single academic medical center. SUBJECTS: Forty-four critical care clinicians with limited extracorporeal membrane oxygenation experience. INTERVENTIONS: Participants were randomized to receive: 1) simulation: three high-fidelity training scenarios, 2) QuizTime: 15 total multiple-choice questions delivered over 3 weeks via mobile device, or 3) experiential: no formal training. Participants completed a survey, written knowledge examination, and simulation assessment prior to randomization, immediately following the intervention, and 4 month postintervention. MEASUREMENTS AND MAIN RESULTS: The primary outcome was knowledge about extracorporeal membrane oxygenation assessed by score on the immediate postintervention written examination. Secondary outcomes included performance in extracorporeal membrane oxygenation simulation postintervention and 4 months later assessed by a rater blinded to group assignment. Clinicians randomized to simulation (n = 15), QuizTime (n = 14), and experiential (n = 15) had similar baseline characteristics. Adjusting for baseline knowledge, postintervention examination scores were higher in the simulation group (90.0%; interquartile range, 85.0–90.0%) than the QuizTime group (70.0%; interquartile range, 65.0–80.0%; p = 0.0003) and the experiential group (75.0%; interquartile range, 65.0–80.0%; p = 0.001). Scores did not differ between the groups at 4 months (p > 0.05 in all analyses). In postintervention extracorporeal membrane oxygenation simulations, the simulation group demonstrated shorter time to critical action compared with QuizTime (80.0 s [interquartile range, 54.0–111.0 s] vs 300.0 s [interquartile range 85.0–300.0 s]; p = 0.02) and compared with both QuizTime (45.0 s [interquartile range, 34.0–92.5 s] vs 255.5 s [interquartile range, 102.0–300.0 s]; p = 0.008) and experiential (300.0 s [interquartile range, 58.0–300.0 s]; p = 0.009) at 4 months. CONCLUSIONS: Simulation was superior to QuizTime and experiential learning with regard to extracorporeal membrane oxygenation knowledge acquisition. Further studies are needed to ascertain the effect of these interventions on knowledge retention, clinical performance, and patient outcomes.


  • Open Access

    Bleeding, Thromboembolism, and Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation

    by John W. Stokes, Whitney D. Msn Gannon, Wren H. Agacnp-Bc Sherrill, Leslie B. Agacnp-Bc Armistead, Matthew Md Bacchetta, Todd W. Md Rice, Matthew W. Md Semler, Jonathan D. Md Casey

    Objectives: Bleeding and thromboembolism are common during venovenous extracorporeal membrane oxygenation. The relative frequency of these complications and their impact on clinical outcomes have not been described, and no randomized trials exist to guide anticoagulation strategies in extracorporeal membrane oxygenation. Our objective was to examine the relative frequencies of bleeding and thromboembolic events and their associations with survival among a cohort of consecutive patients receiving venovenous extracorporeal membrane oxygenation. Design: Retrospective cohort study. Setting: A single academic medical center. Patients: Adult patients receiving venovenous extracorporeal membrane oxygenation and anticoagulation. Eligibility criteria for this analysis were selected to emulate the population that would be recruited for a randomized trial of anticoagulation strategies during venovenous extracorporeal membrane oxygenation. Patients were excluded if they had active bleeding or thromboembolism prior to extracorporeal membrane oxygenation initiation, a history of trauma or surgery in the 7 days prior to extracorporeal membrane oxygenation initiation, an arterial extracorporeal membrane oxygenation cannula, or if they received greater than 48 hours of extracorporeal membrane oxygenation support at another institution Interventions: None. Measurements and Main Results: Outcomes included bleeding and thromboembolic events, duration of extracorporeal membrane oxygenation support, hospital length of stay, and in-hospital survival among 55 patients receiving venovenous extracorporeal membrane oxygenation. Bleeding events occurred in 25 patients (45.5%), and thromboembolism occurred in eight patients (14.5%). Bleeding events were associated with longer duration of extracorporeal membrane oxygenation support (p = 0.007) and worse in-hospital survival (p = 0.02). Thromboembolic events did not appear to be associated with clinical outcomes. Conclusions: In this cohort of patients receiving venovenous extracorporeal membrane oxygenation and anticoagulation, bleeding occurred more frequently than thromboembolism and was associated with worse survival. These results highlight the need for randomized trials to evaluate the safety and efficacy of continuous IV anticoagulation among patients receiving venovenous extracorporeal membrane oxygenation.